Peptide SynthesisMarket Synopsis:
Peptide Synthesis Market Size Was Valued at USD 701.0 Million in 2023, and is Projected to Reach USD 425.2 Million by 2032, Growing at a CAGR of 7.3% From 2024-2032.
Peptide synthesis means the formation of peptides which are small polymer of amino acids by chemical or enzymatic synthesis. These peptides play greater importance in several biotechnological and pharmaceutical areas such as in drug synthesis and identification, diagnosis, and production of vaccines among others. peptide synthesis products involve equipment, products and supplies utilized in the synthesis of peptides of the pharmaceutical, biotechnology and research industry.
The global peptide synthesis market is a relatively new and rapidly growing market primarily due to the increasing advancements in biotechnology and peptide based therapeutic and diagnostic products. Peptides are becoming considered as drug candidates because they can modulate disease pathways selectively with less side effects than small molecules. Furthermore, it can also be said that peptides also find their application in the diagnosis and prognosis of various diseases acts as biomarkers that will in turn drive the demand and market growth. With new therapies being sought after increasingly in the oncology, diabetes, and autoimmune diseases amongst others, the significance of the [peptide synthesis] market will only grow.
The market is also benefited from the advancing technologies in peptide synthesis such as SPPS, LPSS, and hybrid synthesis techniques that made the large scale, efficient and cheap synthesis of peptides. The possibility to order custom peptide synthesis from numerous biotechnology companies has also contributed to the liberalization of the availability of peptides in research laboratories and clinics. Given the prospects of the further development of the biopharmaceutical business and the increasing need for the patient-specific treatment, the peptide synthesis market is expected to demonstrate a constant pace of growth in the next few years.
Peptide Synthesis Market Trend Analysis:
Increasing Demand for Peptides in Drug Discovery
- Peptides are more and more employed in drug discovery and development due to their remarkable selectivity and minimal side effects when compared with conventional small molecular drugs. Peptide therapeutics have been in vogue in recent years due to their possible to identify and modulate protein-protein interactions that small molecules have limitations to reach. It could be therefore predicted that as the world continue to engage in more research studies on peptide based products this will registrar increase in the need for synthesis of peptides. These peptides are used in clinical trials of several diseases such as cancer, diabetes and infections diseases. There has been a vast development in the interest of its usage in biologics and targeted therapies; thus, resulting in a reinforced peptide synthesis pipeline, which has been vital in the peptides drug market.
Expanding Applications in Personalized Medicine
- The largest possible scope in the peptide synthesis market is expected to be fueled by the fact that there is growing call for customized medicine. Individualized care, that is, the approach to the treatment of patients in accordance with their genotype and phenotype, as well lifestyle factors and other features, is one of the recognized tendencies of the modern medicine. This is where peptides are be able to effectively intervene since in contrast to more broad action, peptides can potentially forward this messaging and need towards personalized therapies. Specific peptides are being designed to be used in drugs, diagnostic tools, and immunotherapy, all of which are key concepts of personalized medicine. Since patient customer base demands unique treatments in lieu of symptoms, the synthesis of peptides will prove to be essential in the identification of new therapies, and hence, a large market for the major players currently in the market.
Peptide Synthesis Market Segment Analysis:
Peptide Synthesis Market is Segmented on the basis of Product, Technology, Application, End User, and Region.
By Product, Reagents & Consumables segment is expected to dominate the market during the forecast period
- Thus, the product reagents and consumables segment should remain the market leaders during the forecast period, as they can be required by various industries, such as healthcare, pharmaceuticals, biotechnology, or environmental management. Industrial by-product reagents that are commonly used in the many chemical/bio-chemical reactions go up as more and more industries seek ways in making their business operations efficient. All these reagents play critical roles in diagnostics, research and development and are versatile reagents used in all fields of laboratory applications. Therefore, it can be understood that this market will continue to develop quickly, thanks to consistent improvements in automation and analytical technologies that will require increasing amounts of by-product reagents.
- On the other hand, consumables which include a vast number of products that are used only once in laboratories such as instruments, diagnostic kits, and different instruments are experiencing a massive sales boost as industries strive to maintain high quality, safety, and work on the effectiveness of their operations. Newer requirements such as the advancement in world healthcare, more and more investments in the biotechnology segment, and a rise in clinical trials help to drive the demand for consumables. Also, the emphasis on using less resources and maximizing the efficiency of work has caused an increase in the consumption of disposable products, thus strengthening key segments’ positions on the market during the foreseen period. The increase in by-product reagents and consumables emphasizes the development of these products to cater to the new demands of different industries across the globe.
By Technology, Solid Phase segment expected to held the largest share
- Based on the solid phase technology segment, this market is expected to have the largest share during the forecast period as this technique is widely applicable and highly effective in many analytical and diagnostic procedures. Among these technologies, solid-phase technology applied in solid materials to catalyze reactions or to perform separations is highly preferable due to the factors such as increased rate of reaction, improved purity of the product, and shortened processing time. Where sample preparations, chromatography, immunoassays and other tests are frequently employed, solid-phase methods are especially preferred due to their efficiency and accuracy. It is also essential for the creation of newer diagnostic tools and biomarkers which are a force to the increasing use of this technology across the health and Biotechnology industries.
- Another factor that is boosting the solid development concerns its versatility and opportunities to be expanded to other sectors, pharma, ecology, and food quality control, for instance. An ever increasing need for better, cheaper, and more reproducible methods is placing industries on a solid-phase technologies. These method can be integrated into automated systems and typically produce high degree of standardization and accuracy that is suitable for laboratories and research facilities. Because businesses are becoming more committed to speeding up their operations or manufacturing cycles while reducing errors, the global market’s solid-phase technology segment is expected to maintain its market leadership over the next several years.
Peptide Synthesis Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- Thus, the state of affairs in 2023 stipulated North America as the leading market of the peptide synthesis with a significant share of the global market. The region has contributed the most because of its high levels of research and development, outsourcing, large number of key pharmaceutical and biotechnology companies and enhanced healthcare facilities. The US has some of the greatest biotechnological companies and universities dealing with issues of biotechnology, pharmaceuticals, and health care, which has enhanced the need for peptide-based theranostics. Increased occurrences of peptide therapeutics and tremendous funding on health care research by the government have, therefore, established North America as the market leader.
- The second important region for the peptide synthesis is Europe; major players operating in the region are Germany, the United Kingdom, and Switzerland. However, North America was believed to have a 40-45% market in 2023 and Europe a 30% market. The Asia-Pacific region, however, is also set to become a key market for contender because of rising interest in biotechnology research, improving expenditure on healthcare and a growing trends towards personalised medicine.
Active Key Players in the Peptide Synthesis Market
- AminoTech (USA)
- AnaSpec, Inc. (USA)
- Bachem Holding AG (Switzerland)
- Biomatik Corporation (Canada)
- Cem Corporation (USA)
- GenScript Biotech Corporation (China)
- Lonza Group (Switzerland)
- Merck Group (Germany)
- Peptide Protein Research Ltd (UK)
- Peptide Synthetics (UK)
- PolyPeptide Group (Sweden)
- Sigma-Aldrich (USA)
- SyntheTech, Inc. (USA)
- Thermo Fisher Scientific (USA)
- VWR International, LLC (USA), and Other Active Players
|
Global Peptide Synthesis Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 425.2 Million |
|
Forecast Period 2024-32 CAGR: |
7.3% |
Market Size in 2032: |
USD 701.0 Million |
|
Segments Covered: |
By Product |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Peptide Synthesis Market by Product
4.1 Peptide Synthesis Market Snapshot and Growth Engine
4.2 Peptide Synthesis Market Overview
4.3 Reagents & Consumables
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Reagents & Consumables: Geographic Segmentation Analysis
4.4 Equipment
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Equipment : Geographic Segmentation Analysis
4.5 Peptide Synthesizers
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Peptide Synthesizers: Geographic Segmentation Analysis
4.6 Lyophilizer
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Lyophilizer : Geographic Segmentation Analysis
4.7 Chromatography Equipment
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Chromatography Equipment: Geographic Segmentation Analysis
Chapter 5: Peptide Synthesis Market by Technology
5.1 Peptide Synthesis Market Snapshot and Growth Engine
5.2 Peptide Synthesis Market Overview
5.3 Solid Phase
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Solid Phase: Geographic Segmentation Analysis
5.4 Liquid Phase
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Liquid Phase: Geographic Segmentation Analysis
5.5 Hybrid and Recombinant
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Hybrid and Recombinant: Geographic Segmentation Analysis
Chapter 6: Peptide Synthesis Market by Application
6.1 Peptide Synthesis Market Snapshot and Growth Engine
6.2 Peptide Synthesis Market Overview
6.3 Therapeutics Metabolic Disorders
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Therapeutics Metabolic Disorders: Geographic Segmentation Analysis
6.4 Cardiovascular Disorders
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Cardiovascular Disorders: Geographic Segmentation Analysis
6.5 Respiratory Disorders
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Respiratory Disorders : Geographic Segmentation Analysis
6.6 Infectious Diseases
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Infectious Diseases : Geographic Segmentation Analysis
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation Analysis
6.8 Diagnosis
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Diagnosis : Geographic Segmentation Analysis
6.9 Research
6.9.1 Introduction and Market Overview
6.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.9.3 Key Market Trends, Growth Factors and Opportunities
6.9.4 Research: Geographic Segmentation Analysis
Chapter 7: Peptide Synthesis Market by End User
7.1 Peptide Synthesis Market Snapshot and Growth Engine
7.2 Peptide Synthesis Market Overview
7.3 Biopharmaceutical Companies
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Biopharmaceutical Companies: Geographic Segmentation Analysis
7.4 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO) : Geographic Segmentation Analysis
7.5 Research Institutes
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Research Institutes: Geographic Segmentation Analysis
7.6 Others
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Others: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Peptide Synthesis Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 AMINOTECH (USA)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 ANASPEC INC. (USA)
8.4 BACHEM HOLDING AG (SWITZERLAND)
8.5 BIOMATIK CORPORATION (CANADA)
8.6 CEM CORPORATION (USA)
8.7 GENSCRIPT BIOTECH CORPORATION (CHINA)
8.8 LONZA GROUP (SWITZERLAND)
8.9 MERCK GROUP (GERMANY)
8.10 PEPTIDE PROTEIN RESEARCH LTD (UK)
8.11 PEPTIDE SYNTHETICS (UK)
8.12 POLYPEPTIDE GROUP (SWEDEN)
8.13 SIGMA-ALDRICH (USA)
8.14 SYNTHETECH INC. (USA)
8.15 THERMO FISHER SCIENTIFIC (USA)
8.16 VWR INTERNATIONAL LLC (USA)
8.17 OTHER ACTIVE PLAYERS
Chapter 9: Global Peptide Synthesis Market By Region
9.1 Overview
9.2. North America Peptide Synthesis Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product
9.2.4.1 Reagents & Consumables
9.2.4.2 Equipment
9.2.4.3 Peptide Synthesizers
9.2.4.4 Lyophilizer
9.2.4.5 Chromatography Equipment
9.2.5 Historic and Forecasted Market Size By Technology
9.2.5.1 Solid Phase
9.2.5.2 Liquid Phase
9.2.5.3 Hybrid and Recombinant
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Therapeutics Metabolic Disorders
9.2.6.2 Cardiovascular Disorders
9.2.6.3 Respiratory Disorders
9.2.6.4 Infectious Diseases
9.2.6.5 Others
9.2.6.6 Diagnosis
9.2.6.7 Research
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Biopharmaceutical Companies
9.2.7.2 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
9.2.7.3 Research Institutes
9.2.7.4 Others
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Peptide Synthesis Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product
9.3.4.1 Reagents & Consumables
9.3.4.2 Equipment
9.3.4.3 Peptide Synthesizers
9.3.4.4 Lyophilizer
9.3.4.5 Chromatography Equipment
9.3.5 Historic and Forecasted Market Size By Technology
9.3.5.1 Solid Phase
9.3.5.2 Liquid Phase
9.3.5.3 Hybrid and Recombinant
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Therapeutics Metabolic Disorders
9.3.6.2 Cardiovascular Disorders
9.3.6.3 Respiratory Disorders
9.3.6.4 Infectious Diseases
9.3.6.5 Others
9.3.6.6 Diagnosis
9.3.6.7 Research
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Biopharmaceutical Companies
9.3.7.2 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
9.3.7.3 Research Institutes
9.3.7.4 Others
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Peptide Synthesis Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product
9.4.4.1 Reagents & Consumables
9.4.4.2 Equipment
9.4.4.3 Peptide Synthesizers
9.4.4.4 Lyophilizer
9.4.4.5 Chromatography Equipment
9.4.5 Historic and Forecasted Market Size By Technology
9.4.5.1 Solid Phase
9.4.5.2 Liquid Phase
9.4.5.3 Hybrid and Recombinant
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Therapeutics Metabolic Disorders
9.4.6.2 Cardiovascular Disorders
9.4.6.3 Respiratory Disorders
9.4.6.4 Infectious Diseases
9.4.6.5 Others
9.4.6.6 Diagnosis
9.4.6.7 Research
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Biopharmaceutical Companies
9.4.7.2 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
9.4.7.3 Research Institutes
9.4.7.4 Others
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Peptide Synthesis Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product
9.5.4.1 Reagents & Consumables
9.5.4.2 Equipment
9.5.4.3 Peptide Synthesizers
9.5.4.4 Lyophilizer
9.5.4.5 Chromatography Equipment
9.5.5 Historic and Forecasted Market Size By Technology
9.5.5.1 Solid Phase
9.5.5.2 Liquid Phase
9.5.5.3 Hybrid and Recombinant
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Therapeutics Metabolic Disorders
9.5.6.2 Cardiovascular Disorders
9.5.6.3 Respiratory Disorders
9.5.6.4 Infectious Diseases
9.5.6.5 Others
9.5.6.6 Diagnosis
9.5.6.7 Research
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Biopharmaceutical Companies
9.5.7.2 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
9.5.7.3 Research Institutes
9.5.7.4 Others
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Peptide Synthesis Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product
9.6.4.1 Reagents & Consumables
9.6.4.2 Equipment
9.6.4.3 Peptide Synthesizers
9.6.4.4 Lyophilizer
9.6.4.5 Chromatography Equipment
9.6.5 Historic and Forecasted Market Size By Technology
9.6.5.1 Solid Phase
9.6.5.2 Liquid Phase
9.6.5.3 Hybrid and Recombinant
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Therapeutics Metabolic Disorders
9.6.6.2 Cardiovascular Disorders
9.6.6.3 Respiratory Disorders
9.6.6.4 Infectious Diseases
9.6.6.5 Others
9.6.6.6 Diagnosis
9.6.6.7 Research
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Biopharmaceutical Companies
9.6.7.2 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
9.6.7.3 Research Institutes
9.6.7.4 Others
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Peptide Synthesis Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product
9.7.4.1 Reagents & Consumables
9.7.4.2 Equipment
9.7.4.3 Peptide Synthesizers
9.7.4.4 Lyophilizer
9.7.4.5 Chromatography Equipment
9.7.5 Historic and Forecasted Market Size By Technology
9.7.5.1 Solid Phase
9.7.5.2 Liquid Phase
9.7.5.3 Hybrid and Recombinant
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Therapeutics Metabolic Disorders
9.7.6.2 Cardiovascular Disorders
9.7.6.3 Respiratory Disorders
9.7.6.4 Infectious Diseases
9.7.6.5 Others
9.7.6.6 Diagnosis
9.7.6.7 Research
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Biopharmaceutical Companies
9.7.7.2 Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
9.7.7.3 Research Institutes
9.7.7.4 Others
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Peptide Synthesis Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 425.2 Million |
|
Forecast Period 2024-32 CAGR: |
7.3% |
Market Size in 2032: |
USD 701.0 Million |
|
Segments Covered: |
By Product |
|
|
|
By Technology |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
